Thermo Fisher Scientific Inc. (TMO)

212.99
3.00 1.40
NYSE : Health Technology
Prev Close 215.97
Open 215.83
Day Low/High 213.44 / 216.38
52 Wk Low/High 170.07 / 226.44
Volume 223.88K
Avg Volume 1.37M
Exchange NYSE
Shares Outstanding 402.32M
Market Cap 87.20B
EPS 5.60
P/E Ratio 38.46
Div & Yield 0.68 (0.28%)

Latest News

The New #234 Most Shorted S&P 500 Component: Thermo Fisher Scientific

The most recent short interest data has been released for the 04/13/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

An Oversold Rally Has Finally Arrived, But We'll Be Overbought Soon

I also expect the VIX to rise by mid-May.

Jim Cramer: Follow the Bouncing Equities

Jim Cramer: Follow the Bouncing Equities

Markets start day with a bungee jump.

Uncertainty Is the New Market Normal -- And More Severe Tests Are Coming

Uncertainty Is the New Market Normal -- And More Severe Tests Are Coming

There is likely more headline risk to our front than to our rear.

Nike, Zebra Technologies, Blackstone: 'Mad Money' Lightning Round

Nike, Zebra Technologies, Blackstone: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Nike, Zebra Technologies, Blackstone, Ingersoll-Rand, Thermo Fisher Scientific and more.

Trade Barriers and Interest Rates: Cramer's 'Mad Money' Recap (Monday 4/23/18)

Trade Barriers and Interest Rates: Cramer's 'Mad Money' Recap (Monday 4/23/18)

Jim Cramer considers which is worse for stocks: the 10-year Treasury breaching 3% or the tariff battles with China.

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Jim Cramer highlights Spotify, Alkermes, Sorrento Therapeutics, Thermo Fisher Scientific, Kohlberg Kravis Roberts, and more.

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Washington receded and earnings came to the fore, but we're still seeing insane values and some surprises, says Jim Cramer.

Rapid Mycoplasma Testing Method Now Accepted By Regulators For QA/QC And Lot Release

Rapid Mycoplasma Testing Method Now Accepted By Regulators For QA/QC And Lot Release

MycoSEQ Mycoplasma Detection Method can accelerate production timelines for manufacturers of cell and gene therapies, biotherapeutics, vaccines and other cell-culture-based modalities

Rapid Mycoplasma Testing Method Now Accepted By Regulators For QA/QC And Lot Release

Rapid Mycoplasma Testing Method Now Accepted By Regulators For QA/QC And Lot Release

MycoSEQ Mycoplasma Detection Method can accelerate production timelines for manufacturers of cell and gene therapies, biotherapeutics, vaccines and other cell-culture-based modalities

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Who, out there in the health care sector, is safe?

Jim's Daily Rundown

Jim discusses GE, Comcast, Illinois Tool Works, and Abbott Labs, all of which reported earnings Wednesday morning.

Jim's Daily Rundown

In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

The New #181 Most Shorted S&P 500 Component: Thermo Fisher Scientific

The New #181 Most Shorted S&P 500 Component: Thermo Fisher Scientific

The most recent short interest data has been released for the 12/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Jim's Daily Rundown

In today's video, Jim discusses our newest initiation in Constellation Brands, Danaher at the JP Morgan Healthcare conference, and energy stocks.

Cramer: Lessons From the Market and ICR

Cramer: Lessons From the Market and ICR

You can make a case to buy any of the stocks of the companies at ICR.

Thermo Fisher Scientific Moves Up In Analyst Rankings, Passing Salesforce.com

Thermo Fisher Scientific Moves Up In Analyst Rankings, Passing Salesforce.com

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Thermo Fisher Scientific Inc has taken over the #14 spot from Salesforce. om Inc , according to ETF Channel.

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

Amazon Could Gain 20% by Entering Health Care

Amazon Could Gain 20% by Entering Health Care

Moving into higher-margin products could boost Amazon's gross margins by 1,000 basis points, one analyst contends.

TheStreet Quant Rating: A- (Buy)